EarningsQ4 2025 Earnings Report

NurExone Biologic (J90) Q4 2025 Earnings Report

4 Followers

DE:J90 Q4 2025 EPS Results

Actual EPS-€0.02

Consensus EPS-€0.02

Beat/MissBeat by +<€0.01

One Year Ago EPS-€0.01

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ4 2025

Date04/16/2026

TimeBefore Open

Conference CallThursday, April 16, 2026

DE:J90 Upcoming Earnings

NurExone Biologic's next earnings date is estimated for November 20, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 20, 2026	2026 (Q3)	- / -	-0.018	―
Aug 31, 2026	2026 (Q2)	-0.02 / 0.02	-0.021	183.33% (+0.04)
Jun 03, 2026	2026 (Q1)	- / -	-0.018	―
Apr 16, 2026	2025 (Q4)	-0.02 / -0.02	-0.013	-35.00% (>-0.01)
Nov 26, 2025	2025 (Q3)	-0.02 / -0.02	-0.018	0.00% (0.00)
Aug 27, 2025	2025 (Q2)	-0.02 / -0.02	-0.036	40.00% (+0.01)
May 27, 2025	2025 (Q1)	- / -0.01	-0.014	9.09% (<+0.01)
Apr 09, 2025	2024 (Q4)	-0.02 / -0.02	-0.009	-100.00% (>-0.01)
Nov 27, 2024	2024 (Q3)	-0.03 / -0.02	-0.027	33.33% (<+0.01)
Aug 28, 2024	2024 (Q2)	-0.02 / -0.04	-0.018	-100.00% (-0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed